Nivasorexant
- Generic Name
- Nivasorexant
A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2022-02-24
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 22
- Registration Number
- NCT05254548
- Locations
- 🇩🇪
CRS Clinical Research Services Berlin GmbH, Berlin, Germany
Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder
- First Posted Date
- 2021-02-15
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 136
- Registration Number
- NCT04753164
- Locations
- 🇺🇸
NeuorTrials Research Inc, Atlanta, Georgia, United States
🇺🇸Collaborative Neuroscience Network (CNS), Garden Grove, California, United States
🇺🇸Wr-Pri, Llc, Encino, California, United States
Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT03363984
- Locations
- 🇬🇧
Simbec Research Limited, Merthyr Tydfil, Mid Galmorgan, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath